UiPath (PATH) Stock Tumbles 15% on Dramatic Growth Slowdown, Guidance Embeds 'Significant Conservatism' Says Analyst
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
UiPath Inc. (PATH) PT Lowered to $40 at Needham & Company
March 31, 2022 6:59 AM EDTNeedham & Company analyst Scott Berg lowered the price target on UiPath Inc. (NYSE: PATH) to $40.00 (from $85.00) while maintaining a Buy rating following Q4 results.
The analyst commented, "PATH reported strong 4QF22 results, with a one point acceleration in ARR growth (+59% Y/Y) to $925mm... More
UiPath Inc. (PATH) PT Lowered to $35 at BofA Securities
March 31, 2022 6:06 AM EDTBofA Securities analyst Brad Sills lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $50.00) while maintaining a Buy rating.... More
UiPath Inc. (PATH) PT Lowered to $30 at Canaccord Genuity
March 31, 2022 6:02 AM EDTCanaccord Genuity analyst David Hynes Jr. lowered the price target on UiPath Inc. (NYSE: PATH) to $30.00 (from $55.00) while maintaining a Hold rating.... More
UiPath Inc. (PATH) PT Drops 23% to $57.50 at Credit Suisse After Guiding Well Below Consensus
March 31, 2022 5:56 AM EDTCredit Suisse analyst Phil Winslow lowered the price target on UiPath Inc. (NYSE: PATH) to $57.50 (from $75.00) after reporting FQ4 ARR growth accelerating to 59.4% y/y from 57.9% y/y in FQ3. Operating margin increased as well, to 14.5% (vs. consensus 6.6%) from 4.1% y/y in FQ3. However, guidance... More
UiPath Inc. (PATH) PT Lowered to $23 at Wolfe Research
March 31, 2022 5:38 AM EDTWolfe Research lowered its price target on UiPath Inc. (NYSE: PATH) to $23.00 (from $36.00) while maintaining a Peerperform rating.... More
UiPath Inc. (PATH) PT Lowered to $38 at Macquarie
March 31, 2022 5:08 AM EDTMacquarie analyst Frederick Havemeyer lowered the price target on UiPath Inc. (NYSE: PATH) to $38.00 (from $47.00) while maintaining a Outperform rating.... More
UiPath Inc. (PATH) PT Lowered to $35 at Oppenheimer
March 31, 2022 5:03 AM EDTOppenheimer analyst Brian Schwartz lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $56.00) while maintaining a Outperform rating.... More
UiPath Inc. (PATH) PT Lowered to $41 at Morgan Stanley
March 31, 2022 2:57 AM EDTMorgan Stanley analyst Keith Weiss lowered the price target on UiPath Inc. (NYSE: PATH) to $41.00 (from $74.00) while maintaining a Overweight rating.... More
